01430nam 2200469 450 991015523270332120150814081115.01-62257-153-3(CKB)3710000000973779(MiAaPQ)EBC4787183(EXLCZ)99371000000097377920170130h20122012 uy 0engurcnu||||||||rdacontentrdamediardacarrierFDA drug approval elements and considerations /Timothy I. King and Thomas R. Baker, editorsNew York, [New York] :Nova Biomedical,2012.©20121 online resource (154 pages) color illustrationsPharmacology - Research, Safety Testing and RegulationIncludes index.1-62257-091-X Pharmacology-research, safety testing, and regulation series.Drug approvalUnited StatesClinical trialsUnited StatesUnited StatesfastDrug approvalClinical trials615.1072/4King Timothy I.Baker Thomas R.King, Timothy I.,Baker, Thomas R.,MiAaPQMiAaPQMiAaPQBOOK9910155232703321FDA drug approval2882540UNINA